paraproteinemia (monoclonal gammopathy)

From Aaushi
Jump to navigation Jump to search

Etiology

Pathology

Laboratory

* combination has sensitivity of ~100% diagnosing multiple myeloma requiring therapy

Diagnostic procedures

Radiology

More general terms

More specific terms

References

  1. Bataille R, Harousseau JL. Multiple myeloma. N Engl J Med. 1997 Jun 5;336(23):1657-64. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/9171069
  2. Veterans Administration, Mather CA
  3. UpToDate 14.1 (2007) http://www.utdol.com
  4. Jump up to: 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Medical Knowledge Self Assessment Program (MKSAP) 17, 18, 19. American College of Physicians, Philadelphia 2015, 2018, 2022
  5. Katzmann JA, Kyle RA, Benson J et al Screening panels for detection of monoclonal gammopathies. Clin Chem. 2009 Aug;55(8):1517-22 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19520758
  6. Zivkovic SA, Lacomis D, Lentzsch S. Paraproteinemic neuropathy. Leuk Lymphoma. 2009 Sep;50(9):1422-33 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19637090
  7. Rison RA, Beydoun SR. Paraproteinemic neuropathy: a practical review. BMC Neurol. 2016 Jan 28;16:13. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26821540 Free PMC Article
  8. Rosner MH, Edeani A, Yanagita M et al Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance. Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2280-2287. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27526705 Free PMC Article